- $38.06m
- $36.18m
- $0.19m
2019 December 31st | 2020 December 31st | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 6 M | 12 M | 12 M |
Source: | 10-KT | 10-KT | 10-KT | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0 | 0 | 0.193 |
Cost of Revenue | |||||
Gross Profit | — | — | — | — | 0.084 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0 | 0.012 | 0.256 | 3.73 | 5.7 |
Operating Profit | -0 | -0.012 | -0.256 | -3.73 | -5.51 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0 | -0.013 | -0.216 | -3.45 | -5.38 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0 | -0.013 | -0.217 | -3.45 | -5.38 |
Net Income Before Extraordinary Items | |||||
Net Income | -0 | -0.013 | -0.217 | -3.45 | -5.38 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0 | -0.013 | -0.217 | -3.45 | -5.38 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0 | -0.001 | -0.02 | -0.324 | -0.473 |
Dividends per Share |